ARTA
SGMO

A.R.T. Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

A.R.T. Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-114,440
Closed -$1.09M – 1596
2019
Q1 		$1.09M Buy
+114,440
New +$1.17M 0.07% 448
2018
Q3 		– Sell
-46,406
Closed -$658K – 1674
2018
Q2 		$658K Sell
46,406
-108,000
-70% -$1.79M 0.03% 812
2018
Q1 		$2.93M Buy
154,406
+86,600
+128% +$1.85M 0.12% 246
2017
Q4 		$1.11M Buy
+67,806
New +$1.01M 0.05% 578
2017
Q3 		– Sell
-29,146
Closed -$256K – 1619
2017
Q2 		$256K Buy
+29,146
New +$187K 0.01% 1068
2017
Q1 		– Sell
-53,046
Closed -$161K – 1682
2016
Q4 		$161K Buy
+53,046
New +$193K 0.01% 1100
2016
Q2 		– Sell
-59,119
Closed -$357K – 1601
2016
Q1 		$357K Buy
59,119
+7,100
+14% +$42.6K 0.02% 984
2015
Q4 		$474K Buy
+52,019
New +$401K 0.02% 884
2015
Q3 		– Sell
-48,439
Closed -$537K – 1560
2015
Q2 		$537K Sell
48,439
-106,410
-69% -$1.37M 0.02% 967
2015
Q1 		$2.43M Buy
154,849
+131,110
+552% +$2.03M 0.08% 318
2014
Q4 		$361K Buy
23,739
+3,288
+16% +$39.9K 0.01% 1033
2014
Q3 		$220K Sell
20,451
-89,901
-81% -$1.17M 0.01% 1061
2014
Q2 		$1.69M Buy
110,352
+58,670
+114% +$844K 0.09% 330
2014
Q1 		$934K Buy
+51,682
New +$996K 0.05% 524
2013
Q4 		– Sell
-61,852
Closed -$648K – 1485
2013
Q3 		$648K Buy
61,852
+10,699
+21% +$106K 0.04% 664
2013
Q2 		$399K Buy
+51,153
New +$446K 0.01% 959

Other funds holding SGMO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

A.R.T. Advisors's SGMO Position: Q2 2019 in Review

A.R.T. Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2019, closing a stake of 114,440 shares — an estimated $1.09M sold.

A.R.T. Advisors first reported a position in SGMO in Q2 2013 and held it in 16 quarters. The position peaked at $2.93M in Q1 2018. 185 funds tracked by Wall St. Rank hold SGMO as of Q2 2019.

  • A.R.T. Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 114,440 SANGAMO THERAPEUTICS INC shares in Q2 2019, an estimated $1.09M.
  • A.R.T. Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 16 quarters.
  • A.R.T. Advisors's SANGAMO THERAPEUTICS INC position peaked at $2.93M in Q1 2018.
  • 185 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2019.

Based on A.R.T. Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.